ANTI-3,ANTI-8-DIIODO-11,22-DIOXAUNDECACYCLO-[13.7.0.0(1,21).0(2,6).0(4,12).0(7,21).0(10,12).0(10,18).0(13,17).0(16,20)]-DOCOSANE
Compound with spectra: 1 NMR
![ANTI-3,ANTI-8-DIIODO-11,22-DIOXAUNDECACYCLO-[13.7.0.0(1,21).0(2,6).0(4,12).0(7,21).0(10,12).0(10,18).0(13,17).0(16,20)]-DOCOSANE](/api/compound/3XzjyiVIIDn.png?ph=true&h=300&w=458 "ANTI-3,ANTI-8-DIIODO-11,22-DIOXAUNDECACYCLO-[13.7.0.0(1,21).0(2,6).0(4,12).0(7,21).0(10,12).0(10,18).0(13,17).0(16,20)]-DOCOSANE")
| SpectraBase Compound ID | 3XzjyiVIIDn |
|---|---|
| InChI | InChI=1S/C20H18I2O2/c21-15-11-9-10-12(15)18-4-1-3-7-5-2-6(8(4)7)20(18,24-18)14(10)16(22)13(9)19(5)17(3,11)23-19/h3-16H,1-2H2 |
| InChIKey | WMPFZDBLZUVYQW-UHFFFAOYSA-N |
| Mol Weight | 544.17 g/mol |
| Molecular Formula | C20H18I2O2 |
| Exact Mass | 543.93962 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
11,24-DIOXATRIDECACYCLO-[13.11.0.0(1,21).0(2,6).0(4,12).0(5,9).0(7,21).0(10,12).0(10,18).0(13,17).0(16,20).0(22,26).0(23,25)]-HEXACOSANE
Heptacyclo(8.5.1.0/2,9/.0/3,8/,.0/3,14/.0/8,12/.0/11,15/)hexadecane
Cholic acid, 4TMS
Cholic acid tetra(trimethylsilyl) ester
WESOEMKSFRKZKC-UHFFFAOYSA-N
(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-3,7,12-tris(trimethylsilyloxy)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid methyl ester
Cholan-24-oic acid, 3,7,12-tris[(trimethylsilyl)oxy]-, methyl ester, (3.alpha.,5.alpha.,7.alpha.,12.alpha.)-
Cholan-24-oic acid, 3,7,12-tris[(trimethylsilyl)oxy]-, methyl ester, (3.alpha.,5.beta.,7.alpha.,12.alpha.)-
UFDNTRJTAMHSLG-UHFFFAOYSA-N
8,9,14-TRIHYDRO-4,7-DIAZABICYClO-[3.3.1]-NONANO-[4',5':1,2]-PYRIDO-[3,4-B]-INDOL-6(7H)-ONE
| Title | Journal or Book | Year |
|---|---|---|
| The Pagodane Route to Dodecahedranes Scope and Limitation of the Dehydrocyclization Stratagem | Chemische Berichte | 1992 |